CAS#:2381089-83-2
RT
Size
Research Profile
RT
Literature-based research context for laboratory reference only.
RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.
Selected literature
- Jastreboff et al., 2023, New England Journal of Medicine.
This page is provided for laboratory reference and literature review only. The material is not presented as a consumer product, medical treatment, diagnostic tool, or recommendation for human or animal use.
Overview
RT is presented here as a laboratory reference entry. The Research Profile summarizes literature-based biological context, while this Overview documents the identity record, specification set, preparation format, and quality-reference information available on the page.
The identity block lists CAS number 2381089-83-2, molecular formula C₁₉₈H₃₀₄N₅₂O₆₀, and molecular weight 4,489.1 Da. The material record is paired with ≥99% purity information and a lyophilized presentation for reference review.
Available specification labels include 5mg, 10mg, 20mg, 30mg, 40mg, 50mg, and 60mg. The active selection is 5mg; changing the selector updates the visible specification label and COA lot references while preserving the same research-reference context.
For the active selection, the page currently shows 1 active COA lot reference. COA links, when present, are retained for batch-level purity, identity, and quantity review, while packaging and storage details remain separated in Structure & Identity.